I’m not against the OTCQB at all. It’s a solid
Post# of 88576
What I find interesting is that Dalton stopped labeling things as “UNIVEC OTC” a long time ago. If he intended to stay on the OTC long term, he would have kept using that. Everyone noticed that shift. None of us know exactly what it means, but clearly it was deliberate.
That is why I’m confused when people speak in absolutes. Nobody here knows the internal plan. We are all making interpretations based on what’s been said publicly. The difference is some of us admit we don’t have insider information. Others speak like they are the CEO, as if they know every future step and can declare what is possible and what is not.
Unless you work for the company, you’re making assumptions just like the rest of us. The only honest position is that we don’t know the exact strategy until Dalton files something. Anything beyond that is just opinion dressed up as authority.